BioNTech, Curevac and Co.: Patent Suspensions Threaten Germany’s Booming Biotech Industry




DER SPIEGEL 19/2021











SPIEGEL International







Curevac Co-founder Ingmar Hoerr: A significant Made-in-Germany component.



Curevac Co-founder Ingmar Hoerr: A significant Made-in-Germany component.


Foto: Sebastian Gollnow / dpa





Workers at the BioNTech factory in Marburg



Workers at the BioNTech factory in Marburg


Foto: Thomas Lohnes / AFP

More on the Vaccination Campaign

“Our situation would look quite a bit different if we had had a strong partner on board by last summer.”

CureVac CEO Franz-Werner Haas





Source link

Share:

Author: Admin

Leave a Reply

Your email address will not be published. Required fields are marked *